Crucial data on AstraZeneca's vaccine are coming. Here's what we may learn.

Three coronavirus vaccines are available for use in the U.S. Each were endorsed with little drama by the Food and Drug Administration after clearly positive results in clinical trials.

But the outlook is less clear for what could soon be the fourth vaccine up for review in the U.S., a shot developed by AstraZeneca and the University of Oxford.